Preterm births occur in approximately 12% of pregnancies and it is the leading cause of neonatal mortality in the United States.
Introduction
Preterm births occur in approximately 12% of pregnancies and it is the leading cause of neonatal mortality in the United States. 1, 2 In addition to the high perinatal mortality, the risk of later neurodevelopmental impairment, disability and handicap are especially significant within the 24-26 weeks gestational age window. 3 Up to 40% of survivors born before 26 weeks gestation were found to have a head circumference below 3 rd centile at two years of age after which little catch up growth is possible. 4 Successful reduction of perinatal mortality and morbidity associated with prematurity may require implementation of programs for accurate identification of pregnant women at risk. In fact, recent evidence suggests that early identification of at-risk pregnancies with timely referral for sub specialized obstetrical care may decrease morbidities of extreme prematurity (<32 weeks). 5 A short or partially dilated cervix may allow bacteria to ascend into the lower pole of the uterus where inflammatory response will be triggered. This then leads to cervical ripening and shortening, decreasing the ability of the cervix to act as a mechanical or microbiological barrier and, ultimately leads to the development of either localized or generalized chorio-amnionitis and leads to preterm delivery. 6 However, it's also possible that with a high number of virulent pathogens in the vagina, bacteria may gain access to the lower pole of the uterus through a normally functioning cervix and then ripening of cervix will happen. Bacteria may also gain access to the amniotic cavity through hematogenous spread or by introduction at the time of invasive procedures. 6 Hematogenous spread can also be from oral bacteria although studies of intensive dental hygiene in pregnancy have not shown to reduce the risk. 7, 8 The earliest births carry Background and objective: Estimation of C-reactive protein is a simple method and could be helpful in detecting cases at risk for pre-term delivery. In this study we examined the association of maternal C-reactive protein in second trimester with risk of occurrence of preterm delivery later on. Methods: A prospective case-cohort study was conducted between June 2011 and Julythe highest risk of an infection as etiology. 9 Although the patho-physiology of preterm delivery remains unknown, importantly, some investigators have indicated that infections are major causes of preterm deliveries (PTD), responsible for about 30%-50% of all cases. 10, 11 Moreover there is increasing evidence, which suggests that other infectious processes occurring elsewhere in the body may contribute to preterm delivery. 12, 13 C-reactive protein (CRP) is a protein found in the blood, the levels of which rise in response to inflammation. 14 It is an acute-phase reactant protein synthesized primarily by liver cells in response to the proinflammatory cytokines including interleukin -6 and TNF-α. 15, 16 CRP concentrations in peripheral circulation are also known to be associated with high body mass index (BMI) and other markers of adiposity. 17, 18 On the same basis ladies with BMI ≥30 were excluded from the study. Elevation of C-reactive protein in maternal peripheral circulation is associated with the presence of intrauterine infection. 19, 20 Endothelial dysfunction has been postulated to be part of an exaggerated maternal inflammatory response to pregnancy. 21 In addition, cross -sectional analyses indicate that CRP is strongly correlated with markers of endothelial activation and dysfunction. 22 Collectively, these findings, suggest that C-reactive protein, a marker of systemic inflammation, may be involved in the pathogenesis of preterm delivery. Hvilsom et al in 2002 23 were among the first group of investigators to report that elevated concentrations of CRP in maternal serum during early pregnancy (≥ 85th percentile vs. <85th percentile) were associated with a two-fold increased risk of preterm delivery (OR = 2.0, 95% CI: 1.2-3.5). Some others have corroborated this early finding, 24, 25 though not all investigators. 26 The aim of this study was to assess the association of CRP, a marker of inflammation, with preterm delivery, to examine the reliability of CRP in maternal serum as a marker of premature birth among pregnant women who had no of the known risks for premature birth and to determine critical value of CRP in pregnancies that ended up with a premature birth.
Methods
The , planned to carry the pregnancy to term, and to deliver at study hospital. Both nulliparous and multiparous women were approached and enrolled. They were asked to take part in an hour-long interview in which trained personnel used a structured questionnaire to get information about maternal sociodemographic characters, maternal age, occupation and reproductive and medical history. Participants also provided nonfasting blood sample for estimation of CRP, high vaginal swab, mid stream urine for analysis and culture and sensitivity, and trans-vaginal sonography for measurement of cervical length. The BMI was taken from booking records. Pregnancy outcome information was ascertained by a direct contact with the participants. During the study period, 208 eligible women were approached, and all gave a well-informed verbal consent. Three women were lost from follow up and were excluded from the analysis. Any woman at risk for pre-term birth such as having a history of pre-term birth, cervical incompetence, urinary tract infection (proved by urine test), bacterial vaginosis, diabetes (gestational or non gestational), hypertension, multiple gestations, poly-hydramnios, uterine congenial abnormality, placenta previa, and BMI ≥30 was excluded from the study. Gestational age was based on the last menstrual period (LMP) and confirmed by ultrasound examination, conducted prior to 20 weeks gestation. If both last menstrual period and ultrasound dating were available and the difference between ultrasound and LMP exceeded one week then the ultrasound dating was used to assign gestational age. We categorized preterm delivery cases according to gestational age. Serum CRP levels were measured by quantitative highly sensitive immunoassay test (the i-CHROMATM CRP Test along with i-CHROMATM Reader). It is a fluorescence immunoassay that measures CRP in serum, plasma, and whole blood. A single technician and a single laboratory specialist did all the tests by ELISA method. The lab staff members were blinded for the blood samples. Maternal non-fasting blood samples were collected at gestational age 21.8 (The mean gestational age at time of sampling) in 10 ml test tube without anticoagulant and allowed to clot. The serum was then removed from the sample as soon as possible to avoid hemolysis. Samples were kept frozen until tested. A levels ≥10 mg/l was considered being high. Patients were followed up until delivery and the gestational age at the time of delivery was noted. Statistical analysis and ethical consideration: The distribution of maternal socio-demographic characteristics, medical and reproductive histories according to preterm and term delivery status was examined. To estimate the relative association between varying concentrations of CRP and risk of preterm delivery, the data was analyzed using the statistical package for the social sciences (version 18). Student's t test was used to compare between means and Chi square test of association was used to compare between proportions. P value of ≤0.05 was considered statistically significant. The scientific and ethical committee of the Council of Arab Council for Medical Specialties approved the study. There was no statistically significant relation between high CRP value in second trimester of pregnancy and preterm delivery (P = 0.781). Table 3 shows the relation between the CRP values and the different variables in the study, which shows no significant relation. Both primi-gravida and multigravid was were included in the study and there was no significant relation between parity and CRP level as shown in Table 4 . Table 5 shows the relation between very high level of CRP and preterm labor. In this 
Results

Discussion
In the current study we found that there was no association between midpregnancy maternal serum CRP and preterm delivery as the mean and the median of CRP in preterm deliveries (8.09 and 6.59 mg/l, respectively) did not differ significantly from the mean and median serum CRP in term deliveries (7.05 and 4.64 mg/l, respectively). This finding was similar to Ghezzi F et al 27 in which no relationship was found between maternal blood C-reactive protein concentration and preterm delivery. Another study done by Borna et al 28 showed no correlation between amniotic fluid high sensitive-CRP concentrations with preterm delivery. Ozer et al 29 did not find any difference with respect to mean high sensitive-CRP levels between term and preterm deliveries and high sensitive-CRP levels higher than 5 mg/l (75 th percentile) had sensitivity of 30%, specificity of 87% in the prediction of spontaneous preterm delivery at <37 weeks. While Pitiphat et al 24 subsequently became ineligible because of multiple gestation (n = 19), because obstetric care was transferred to a non study site (n = 115), or because the women were no longer pregnant (n = 195). Of the 2,341 remaining participants, 195 (8%) withdrew and 18 (<1 percent) were lost to follow-up. For this analysis, of the 2,128 participants who delivered a live infant, they included the 2,088 women who also provided blood samples in early pregnancy. They found no significant association between quartiles of CRP and preterm delivery. They also found that very high levels of maternal plasma CRP in early pregnancy were associated with increased risk of preterm delivery. In this study we found that the percentage of preterm delivery in very high level of CRP ≥20 mg/l (21.4%) was more than that in CRP level of <20mg/l (11%) but this finding was not statistically significant. This may be due to small sample size, as only five pregnant ladies who delivered pre-term had high CRP value, and only three cases had very high CRP level. Hvilsom et al, 23 in their prospective case-control study of cohort of 84 singleton preterm cases and 400 term controls, the authors reported that women with CRP concentrations ≥ 85 th percentile (i.e., ≥7.6 mg/l) experienced a two-fold increased risk of preterm delivery (OR = 2.0, 95% CI: 1.2 -3.5) compared with women who had lower CRP concentrations. However, the authors did not assess the risk of different sub-types of preterm delivery in relation to varying concentrations of CRP. The etiology of preterm delivery is undoubtedly multifactorial. It is this multi-factorial etiology that raised difficulties and differences in determining the effectiveness of various markers in the prediction of preterm delivery. 30, 31 Differences in study design, timing of blood collection, the underlying characteristics of the study population, and incomplete or no control for confounding may account for the variability in results across studies. For instance, investigators have noted that serum CRP concentrations measured in the third trimester (28 weeks gestation) is more strongly associated with preterm delivery, while concentrations measured in serum collected upon entry to prenatal care (first and early second trimesters) appear to be less strongly associated with preterm delivery, therefore we designed this study to measure CRP in the middle and late second trimester so we can add some data to those previous studies. The results of this study implicate serum-CRP in the mid second trimester, was not a possible risk marker of preterm delivery. This study had some limitations. First, a single measurement of serum CRP is not likely to provide a time-integrated measure of maternal inflammation status during the whole pregnancy. Second, the relatively small sample size of the study. Thus the relatively small number of cases who delivered preterm, especially those with very high CRP values, affected the results.
Conclusion
Very high CRP levels exceeding the threshold (≥20mg/l) might be associated with increased risk of preterm delivery independent of many other determinants of pre-term delivery. The association was apparent primarily for spontaneous preterm delivery but not significant. Future studies should evaluate whether changes in CRP levels over the course of pregnancy are predictive of at risk pregnancies for pre-term labor and to find the best time of pregnancy to do CRP screening in order to sort out the pregnancies at risk.
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